Drug | Star-PUs | ||||
---|---|---|---|---|---|
 | Cases | Controls | Difference [95% C.I.] | % Difference | |
 |  | Unmatched | Matched |  |  |
Statins* (BNF Chapter 2, 2.12) | 98.9 | 99.4 | 136.7 | -37.8 [-66.7 to -11.5] | -27.7% |
Ace Inhibitors (BNF Chapter 2, 2.5.5) | 104.7 | 97.3 | 144.4 | -39.7 [-64.3 to -14.5] | -27.5% |
Amlodipine BNF Chapter 2, 2.6) | 89.2 | 107.0 | 102.2 | -13.0 [-44.3 to 13.4] | -12.8% |
Beta blockers (BNF Chapter 2, 2.4) | 92.7 | 101.9 | 106.2 | -13.5 [-38.9 to 9.9] | -12.7% |
Clopidogrel (BNF Chapter 2, 2.9) | 86.6 | 99.6 | 154.3 | -67.6 [-105.8 to -17.8] | -43.9% |
Thiazide ((BNF Chapter 2, 2.5) | 92.7 | 103.4 | 134.8 | -42.2 [-62.7 to -23.6] | -31.3% |
Aspirin (BNF Chapter 2, 2.9) | 109.0 | 102.2 | 136.2 | -27.2 [-57.7 to 3.6] | -20% |
Warfarin (BNF Chapter 2, 2.8) | 77.2 | 100.2 | 101.7 | -24.5 [-38.1 to -6.5] | -24.1% |
Spironolactone (BNF Chapter 2, 2.5) | 87.0 | 100.3 | 109.8 | -22.9 [-63.9 to 0.6] | -20.8% |
Digoxin (BNF Chapter 2, 2.1) | 92.0 | 100.9 | 122.6 | -30.6 [-55.7 to -9.6] | -25% |